PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-165.00%
Both yoy net incomes decline, with CRK at -108.62%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
-102.63%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-318.18%
Negative yoy working capital usage while CRK is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-23.40%
Both yoy AR lines negative, with CRK at -77.26%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-160.78%
Negative yoy usage while CRK is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
15.37%
Lower 'other non-cash' growth vs. CRK's 49.94%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-14.41%
Both yoy CFO lines are negative, with CRK at -34.57%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-20.53%
Negative yoy CapEx while CRK is 100.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-378.62%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
205.71%
Growth well above CRK's 100.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-66.05%
We reduce yoy invests while CRK stands at 100.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
115.49%
Debt repayment growth of 115.49% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.